心脏骤停期间主动脉球囊阻断——对肠道的致命打击?
本文为综述,讨论非创伤性心脏骤停中使用复苏性血管内主动脉球囊阻断(REBOA)对肠道缺血的影响。心脏骤停复苏时心输出量降低,静脉肾上腺素可能进一步减少肠系膜血流,胸主动脉球囊阻断可能导致肠道血流完全停止;实验研究表明肠道损伤随REBOA充气时间增加,45-60分钟缺血可能导致不可逆损伤。肠道缺血诊断困难,IFABP在所有心脏骤停患者中升高且与死亡率 striking 关联,CT诊断肠道缺血的患者均死亡,但肠道缺血可能是全身缺血的标志而非独立不良预后因素。作者认为REBOA导致的额外肠道缺血临床重要性可能有限,但尚无定论。
要点
- 实验研究表明肠道损伤随REBOA充气时间增加,45-60分钟缺血可能导致不可逆损伤。
- 心脏骤停复苏时心输出量降低,静脉肾上腺素可能进一步减少肠系膜血流,胸主动脉球囊阻断可能导致肠道血流完全停止。
- 一项研究中IFABP在所有心脏骤停患者中升高,且与死亡率有 striking 关联。
- 另一项研究中CT诊断肠道缺血的所有患者均死亡。
- 作者认为REBOA导致的额外肠道缺血临床重要性可能有限,但尚待回答。
适用人群与场景
- 非创伤性心脏骤停患者。
研究设计与关键结果
- 综述指出,人类关于非创伤性心脏骤停中REBOA的数据有限。
- 实验研究表明肠道损伤随REBOA充气时间增加,45-60分钟缺血可能导致不可逆损伤。
- 一项研究中,肠道损伤生物标志物IFABP在所有心脏骤停患者中升高,且与死亡率有 striking 关联。
- 另一项研究中,CT诊断肠道缺血的所有患者均死亡。
- 肠道缺血可能是全身缺血的标志,而非不良预后的独立因素。
证据类型、等级与局限
- 综述,证据类型为综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,REBOA导致的额外肠道缺血临床重要性可能有限,但尚待回答。
- REBOA球囊充盈发生在患者仍处于心脏骤停时,是达到ROSC的一种手段。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in non-traumatic cardiac arrest may result in worsened intestinal ischaemia. What are the consequences?
MAIN TEXT: Human data on REBOA in non-traumatic cardiac arrest is limited. In general, cardiac output is reduced during resuscitation, and mesenteric blood flow may be further reduced by intravenous adrenaline (epinephrine). Balloon occlusion of the thoracic aorta will potentially lead to a complete cessation of intestinal blood flow. Experimental studies demonstrate that intestinal damage increases with REBOA inflation time, and that 45-60 min of ischaemia may result in irreversible damage. However, it is unclear when intestinal ischaemia starts to affect patient-oriented outcomes. A barrier for assessing the consequences of intestinal ischemia is that it is a challenge to diagnose. A biomarker for intestinal injury, Intestinal Fatty Acid Binding Protein (IFABP), was elevated in all cardiac arrest patients and had a striking association with mortality in one study. In another study, all patients with intestinal ischemia diagnosed on CT died. However, intestinal ischemia could be a marker of whole-body ischemia and not an independent contributor to poor outcome. The clinical importance of worsened intestinal ischemia by REBOA during cardiac arrest is not established.
CONCLUSION: The impact of intestinal ischaemia following cardiac arrest is uncertain, but ischaemia is likely to be exacerbated by REBOA. However, inflation of the balloon will occur when the patient is still in cardiac arrest and is a means to achieve ROSC. Hence, we argue that the added intestinal ischaemia caused by REBOA may be of limited clinical importance, but this is still to be answered.
参考来源
- Farbu BH, Brede J. Balloon occlusion of the aorta during cardiac arrest -a death blow to the intestines? Scand J Trauma Resusc Emerg Med. 2025. PMID: 39915854. doi:10.1186/s13049-025-01321-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。